RECRUITING

Labetalol or Nifedipine for Control of Postpartum Hypertension: A Randomized Controlled Trial

Study Overview

This clinical trial focuses on testing the efficacy of different digital interventions to promote re-engagement in cancer-related long-term follow-up care for adolescent and young adult (AYA) survivors of childhood cancer.

Description

Randomized trial comparing risk of hospital readmission and hypertensive complications between patients managed on Labetalol compared to Nifedipine.

Official Title

Labetalol or Nifedipine for Control of Postpartum Hypertension: A Randomized Controlled Trial

Quick Facts

Study Start:2022-06-20
Study Completion:2024-12-01
Study Type:Not specified
Phase:Not Applicable
Enrollment:Not specified
Status:RECRUITING

Study ID

NCT05309460

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Ages Eligible for Study:19 Years
Sexes Eligible for Study:FEMALE
Accepts Healthy Volunteers:No
Standard Ages:ADULT, OLDER_ADULT
Inclusion CriteriaExclusion Criteria
  1. Age 18 years or older
  2. Willing and able to provide informed consent
  3. Able to understand and follow study procedures
  4. Stable medical condition
  1. * Contraindication to either Nifedipine or Labetalol
  2. * HR \<60 or \>110
  3. * Native language other than English or Spanish

Contacts and Locations

Study Contact

Todd Lovgren, MD
CONTACT
4028151970
todd.lovgren@nmhs.org
Joshua Dahlke, MD
CONTACT
4028151970
joshua.dahlke@nmhs.org

Principal Investigator

Todd Lovgren, MD
PRINCIPAL_INVESTIGATOR
Nebraska Methodist Health System

Study Locations (Sites)

Nebraska Methodist Women's Hospital
Omaha, Nebraska, 68022
United States

Collaborators and Investigators

Sponsor: Nebraska Methodist Health System

  • Todd Lovgren, MD, PRINCIPAL_INVESTIGATOR, Nebraska Methodist Health System

Study Record Dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Registration Dates

Study Start Date2022-06-20
Study Completion Date2024-12-01

Study Record Updates

Study Start Date2022-06-20
Study Completion Date2024-12-01

Terms related to this study

Keywords Provided by Researchers

  • Nifedipine
  • Labetalol
  • Postpartum
  • Hypertension
  • Preeclampsia
  • Pregnancy

Additional Relevant MeSH Terms

  • Postpartum Preeclampsia
  • Hypertension in Pregnancy